Business of Bioanalysis: The Importance of Company Culture in CRO Mergers

Watch Dr. Afshin Safavi, BioAgilytix Global CSO discuss how BioAgilytix took company culture into account when acquiring IPM Biotech as part of the “Business of Bioanalysis” panel hosted by Bioanalysis Zone.

*Video Produced by Bioanalysis Zone

Share This